Key facts
- Notable investors include CNT Tech, Next Elevation.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Nootropic Lab
- ·The full record, as it builds
Funding rounds
No funding rounds for Nootropic Lab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nootropic Lab
Producer of nootropic drinks intended to improve brain function, concentration, cognitive ability, and stress relief. The company offers zero-caffeine and plant-based beverages, based on clinical research, enabling consumers to access alternative energy drinks made from natural substances while supporting the contemporary lifestyle.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Seoul, South Korea
- Founded
- 2022
- Employees
- 2
- Website
- ntplab.co/
- Ownership
- Privately Held (backing)
Nootropic Lab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nootropic Lab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nootropic Lab in its N-PORT filings yet. We sweep new filings monthly.